Demographic data on study populations I and II (n = 20)
| Variable | Study population I | Study population II (n = 20) | |
|---|---|---|---|
| Infliximab treated (n = 10) | Placebo treated (n = 3) | ||
| Values are n or median (range). | |||
| Spondyloarthropathy subtype: AS, ankylosing spondylitis; PsA, psoriatic arthritis; uSpA, undifferentiated spondyloarthropathy. | |||
| HLA, human leucocyte antigen; SpA, spondyloarthropathy. | |||
| SpA subtype (AS/PsA/uSpA) | 5/4/1 | 1/1/1 | 10/8/2 |
| Sex (male/female) | 8/2 | 3/0 | 16/4 |
| Age (years) (median (range)) | 53 (30 to 66) | 54 (44 to 66) | 49 (38 to 66) |
| Disease duration (median (range)) | 14 (1 to 42) | 39 (10 to 40) | 18.5 (1 to 43) |
| HLA B27 (+/−/unknown) | 8/2/0 | 2/1/0 | 13/5/2 |